 FORT COLLINS, Colo., Oct. 05, 2021 GLOBE NEWSWIRE -- Statera Biopharma, Inc. Nasdaq: STAB, a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced that Michael K. Handley, President and Chief Executive Officer, has been invited to participate as an expert speaker during the 2nd Annual B T Cell-Mediated Autoimmune Disease Drug Development Summit. The virtual conference is taking place October 6-7, 2021. 